Tech companies new to the IBD 50 list of top-rated growth stocks this week include IT services provider EPAM Systems (EPAM), genetic testing equipment and systems provider Illumina (ILMN) and China gaming site operator NetEase (NTES). Amazon.com (AMZN) remains the only tech on the IBD Leaderboard. With the market direction at “uptrend under pressure,” however, caution is warranted. Stocks fell broadly Monday on weak China economic data and
Epam Systems (EPAM) stock slipped in late trading Tuesday after the provider of outsourced software engineering and other IT services beat second-quarter revenue expectations but edged earnings views as it again faced foreign currency headwinds. Epam gets more than half its business from outside the U.S., so the strong U.S. dollar has weighed on its results — as it has for IBM (IBM), which also derives the majority of its revenue from
Stocks went for a wild ride this past week, with a swath of earnings reports from big names. But the roller coaster of Q2 results isn’t slowing down just yet. Ten top-rated IBD 50 stocks are all geared up to issue their quarterly performances: Allergan (AGN), Regeneron Pharmaceuticals (REGN), Jazz Pharmaceuticals (JAZZ), Monster Beverage (MNST), Gray Television (GTN), Paycom Software (PAYC), Criteo (CRTO), Epam Systems (EPAM), AMC Networks (AMCX),